RCAMU
GILD icon

Rothschild & Co Asset Management US’s Gilead Sciences GILD Stock Holding History

Rothschild & Co Asset Management US’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-649,606
Closed -$48.6M – 331
2020
Q1 		$48.6M Sell
649,606
-29,721
-4% -$2.05M 0.76% 26
2019
Q4 		$44.1M Sell
679,327
-18,420
-3% -$1.2M 0.46% 71
2019
Q3 		$44.2M Sell
697,747
-14,415
-2% -$942K 0.48% 57
2019
Q2 		$48.1M Sell
712,162
-51,920
-7% -$3.42M 0.51% 47
2019
Q1 		$49.7M Sell
764,082
-856
-0.1% -$56.9K 0.53% 50
2018
Q4 		$47.8M Sell
764,938
-21,912
-3% -$1.53M 0.58% 38
2018
Q3 		$60.8M Buy
786,850
+14,412
+2% +$1.09M 0.62% 26
2018
Q2 		$54.7M Buy
772,438
+946
+0.1% +$66.8K 0.59% 37
2018
Q1 		$58.2M Sell
771,492
-37,588
-5% -$2.99M 0.65% 25
2017
Q4 		$58M Sell
809,080
-31,075
-4% -$2.36M 0.61% 37
2017
Q3 		$68.1M Buy
840,155
+496,469
+144% +$38M 0.75% 21
2017
Q2 		$24.3M Sell
343,686
-330,784
-49% -$22M 0.27% 139
2017
Q1 		$45.8M Buy
674,470
+84,518
+14% +$5.94M 0.53% 48
2016
Q4 		$42.2M Buy
589,952
+99,144
+20% +$7.37M 0.54% 41
2016
Q3 		$38.8M Buy
490,808
+24,288
+5% +$1.97M 0.67% 22
2016
Q2 		$38.9M Sell
466,520
-93,447
-17% -$8.29M 0.7% 26
2016
Q1 		$51.4M Buy
559,967
+44,366
+9% +$4M 0.96% 15
2015
Q4 		$52.2M Buy
515,601
+21,422
+4% +$2.23M 0.95% 13
2015
Q3 		$48.5M Buy
494,179
+141,132
+40% +$15.7M 0.95% 14
2015
Q2 		$41.2M Buy
353,047
+2,871
+0.8% +$314K 0.76% 30
2015
Q1 		$34.4M Sell
350,176
-774
-0.2% -$78.6K 0.65% 36
2014
Q4 		$33.5M Sell
350,950
-51,131
-13% -$5.29M 0.67% 39
2014
Q3 		$43M Sell
402,081
-29,281
-7% -$2.87M 0.92% 23
2014
Q2 		$35.8M Buy
431,362
+89,443
+26% +$6.96M 0.74% 27
2014
Q1 		$24.2M Buy
341,919
+178,738
+110% +$14M 0.54% 43
2013
Q4 		$12.3M Buy
+163,181
New +$11.4M 0.27% 120

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Rothschild & Co Asset Management US's GILD Position: Q2 2020 in Review

Rothschild & Co Asset Management US sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 649,606 shares — an estimated $48.6M sold.

Rothschild & Co Asset Management US first reported a position in GILD in Q4 2013 and held it in 26 quarters. The position peaked at $68.1M in Q3 2017. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Rothschild & Co Asset Management US reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 649,606 Gilead Sciences shares in Q2 2020, an estimated $48.6M.
  • Rothschild & Co Asset Management US first reported a position in Gilead Sciences in Q4 2013 and held it in 26 quarters.
  • Rothschild & Co Asset Management US's Gilead Sciences position peaked at $68.1M in Q3 2017.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2020, filed 10 Aug 2020.